Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for chronic obstructive pulmonary disease.
作者： Federico P. Gómez , Roberto Rodriguez-Roisin
DOI: 10.1097/00063198-200203000-00001
关键词: Severity of illness 、 Risk assessment 、 Intensive care medicine 、 Global strategy 、 Obstructive lung disease 、 Medicine 、 MEDLINE 、 Pulmonary disease 、 Disease 、 COPD
摘要: … international efforts in the management of the disease. The most important GOLD objective is raising awareness that chronic obstructive pulmonary disease … , named “Global Strategy for …
lww.com
sci-hub.se 参考文章(29)
A. Santhire Vathenen, John R. Britton, Philip Ebden, John B. Cookson, Heather J. Wharrad, Anne E. Tattersfield, High-dose inhaled albuterol in severe chronic airflow limitation. The American review of respiratory disease. ,vol. 138, pp. 850- 855 ,(1988) , 10.1164/AJRCCM/138.4.850
Michael C. Fiore, The Effectiveness of the Nicotine Patch for Smoking Cessation JAMA. ,vol. 271, pp. 1940- 1947 ,(1994) , 10.1001/JAMA.1994.03510480064036
Jøorgen Vestbo, Torben Søorensen, Peter Lange, Anders Brix, Piero Torre, Kaj Viskum, Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial The Lancet. ,vol. 353, pp. 1819- 1823 ,(1999) , 10.1016/S0140-6736(98)10019-3
H. Chrystyn, B. A. Mulley, M. D. Peake, Dose response relation to oral theophylline in severe chronic obstructive airways disease. BMJ. ,vol. 297, pp. 1506- 1510 ,(1988) , 10.1136/BMJ.297.6662.1506
L Davies, RM Angus, PMA Calverley, Oral Corticosteroids in Patients Admitted to Hospital With Exacerbations of Chronic Obstructive Pulmonary Disease: A Prospective Randomised Controlled Trial The Lancet. ,vol. 354, pp. 456- 460 ,(1999) , 10.1016/S0140-6736(98)11326-0
Paul A. Easton, Carlos Jadue, Saresh Dhingra, Nicholas R. Anthonisen, A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence The New England Journal of Medicine. ,vol. 315, pp. 735- 739 ,(1986) , 10.1056/NEJM198609183151205
N. R. ANTHONISEN, Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease Annals of Internal Medicine. ,vol. 106, pp. 196- 204 ,(1987) , 10.7326/0003-4819-106-2-196
Nicholas J. Gross, Thomas L. Petty, Mitchell Friedman, Morton S. Skorodin, G. Wayne Silvers, James F. Donohue, Dose Response to Ipratropium as a Nebulized Solution in Patients with Chronic Obstructive Pulmonary Disease: A Three-Center Study The American review of respiratory disease. ,vol. 139, pp. 1188- 1191 ,(1989) , 10.1164/AJRCCM/139.5.1188
JA Barberá, G Peces-Barba, AGN Agustí, JL Izquierdo, E Monsó, T Montemayor, JL Viejo, Grupo de Trabajo de la Sociedad, Española de Neumología, None, Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica Archivos De Bronconeumologia. ,vol. 37, pp. 297- 316 ,(2001) , 10.1016/S0300-2896(01)75074-0
EJVIND FRAUSING HANSEN, KLAUS PHANARETH, LARS C. LAURSEN, AXEL KOK-JENSEN, ASGER DIRKSEN, Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine. ,vol. 159, pp. 1267- 1271 ,(1999) , 10.1164/AJRCCM.159.4.9807121